Moxifloxacin for Community-Acquired Pneumonia

por Rijnders, Bart J. A.
Publicado em 2003

Invasive Pulmonary Aspergillosis Goes Viral Again?

por Wauters, Joost, Lamoth, Frederic, Rijnders, Bart J. A., Calandra, Thierry
Publicado no Am J Respir Crit Care Med (2021)

Comparison of the Roll Plate Method to the Sonication Method To Diagnose Catheter Colonization and Bacteremia in Patients with Long-Term Tunnelled Catheters: a Randomized Prospecti...

por Slobbe, Lennert, el Barzouhi, Abdelilah, Boersma, Eric, Rijnders, Bart J. A.
Publicado em 2009

Influenza-Associated Pulmonary Aspergillosis: A Local or Global Lethal Combination?

por Rijnders, Bart J A, Schauwvlieghe, Alexander F A D, Wauters, Joost
Publicado no Clin Infect Dis (2020)

Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?

por Martin, Natasha K, Boerekamps, Anne, Hill, Andrew M, Rijnders, Bart J A
Publicado no J Int AIDS Soc (2018)

Persistent candida arthritis successfully treated with micafungin instillation and surgery. A case report

por van Egmond, Jeroen C., Hunfeld, Nicole G.M., Rijnders, Bart J.A., Verhaar, Jan A.N.
Publicado no Med Mycol Case Rep (2019)

Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patients

por Vehreschild, Jörg Janne, Koehler, Philipp, Lamoth, Frédéric, Prattes, Juergen, Rieger, Christina, Rijnders, Bart J A, Teschner, Daniel
Publicado no Med Mycol (2020)

HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study

por Hullegie, Sebastiaan J., GeurtsvanKessel, Corine H., van der Eijk, Annemiek A., Ramakers, Chris, Rijnders, Bart J. A.
Publicado no J Int AIDS Soc (2017)

Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B

por Adler-Moore, Jill, Lewis, Russell E, Brüggemann, Roger J M, Rijnders, Bart J A, Groll, Andreas H, Walsh, Thomas J
Publicado no Clin Infect Dis (2019)

Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B

por Groll, Andreas H, Rijnders, Bart J A, Walsh, Thomas J, Adler-Moore, Jill, Lewis, Russell E, Brüggemann, Roger J M
Publicado no Clin Infect Dis (2019)

Influenza Coinfection: Be(a)ware of Invasive Aspergillosis

por Verweij, Paul E, Brüggemann, Roger J M, Wauters, Joost, Rijnders, Bart J A, Chiller, Tom, van de Veerdonk, Frank L
Publicado no Clin Infect Dis (2020)

Prevention of Catheter-Related Bacteremia with a Daily Ethanol Lock in Patients with Tunnelled Catheters: A Randomized, Placebo-Controlled Trial

por Slobbe, Lennert, Doorduijn, Jeanette K., Lugtenburg, Pieternella J., el Barzouhi, Abdelilah, Boersma, Eric, van Leeuwen, Willem B., Rijnders, Bart J. A.
Publicado em 2010

Aspergillus in Critically Ill COVID-19 Patients: A Scoping Review

por Yusuf, Erlangga, Seghers, Leonard, Hoek, Rogier A. S., van den Akker, Johannes P. C., Bode, Lonneke G. M., Rijnders, Bart J. A.
Publicado no J Clin Med (2021)

Combination Therapy of Advanced Invasive Pulmonary Aspergillosis in Transiently Neutropenic Rats Using Human Pharmacokinetic Equivalent Doses of Voriconazole and Anidulafungin

por van de Sande, Wendy W. J., Mathot, Ron A. A., ten Kate, Marian T., van Vianen, Wim, Tavakol, Mehri, Rijnders, Bart J. A., Bakker-Woudenberg, Irma A. J. M.
Publicado em 2009

Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America()

por Mermel, Leonard A., Allon, Michael, Bouza, Emilio, Craven, Donald E., Flynn, Patricia, O’Grady, Naomi P., Raad, Issam I., Rijnders, Bart J. A., Sherertz, Robert J., Warren, David K.
Publicado em 2009

Caspofungin Prolongs Survival of Transiently Neutropenic Rats with Advanced-Stage Invasive Pulmonary Aspergillosis

por van de Sande, Wendy W. J., van Vianen, Wim, ten Kate, Marian T., Vissers, Jolanda, Laurijsens, John, Tavakol, Mehri, Rijnders, Bart J. A., Mathot, Ron A. A., Bakker-Woudenberg, Irma A. J. M.
Publicado em 2008

Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007–2009

por van der Linden, Jan W.M., Snelders, Eveline, Kampinga, Greetje A., Rijnders, Bart J.A., Mattsson, Eva, Debets-Ossenkopp, Yvette J., Van Tiel, Frank H., Melchers, Willem J.G., Verweij, Paul E.
Publicado em 2011

High‐dose posaconazole for azole‐resistant aspergillosis and other difficult‐to‐treat mould infections

por Schauwvlieghe, Alexander F. A. D., Buil, Jochem B., Verweij, Paul E., Hoek, Rogier A. S., Cornelissen, Jan J., Blijlevens, Nicole M .A., Henriet, Stefanie S. V., Rijnders, Bart J. A., Brüggemann, Roger J. M.
Publicado no Mycoses (2019)

Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study

por Rokx, Casper, Borjas Howard, Jaime F., Smit, Colette, Wit, Ferdinand W., Pieterman, Elise D., Reiss, Peter, Cannegieter, Suzanne C., Lijfering, Willem M., Meijer, Karina, Bierman, Wouter, Tichelaar, Vladimir, Rijnders, Bart J. A.
Publicado no PLoS Med (2020)

Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B

por van de Peppel, Robert J, Schauwvlieghe, Alexander, Van Daele, Ruth, Spriet, Isabel, van't Wout, Jan W, Brüggemann, Roger J, Rijnders, Bart J A, Hendriks, Bart J C, de Boer, Mark G J
Publicado no Med Mycol (2020)